{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:27:23Z","timestamp":1792801643219,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.ejphar.2013.04.029","type":"journal-article","created":{"date-parts":[[2013,5,9]],"date-time":"2013-05-09T01:20:01Z","timestamp":1368062401000},"page":"58-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP + )-induced cell death via the mitochondrial apoptotic pathway"],"prefix":"10.1016","volume":"713","author":[{"given":"Aifeng","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.04.029_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0168-0102(95)90013-6","article-title":"Survival of and 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity against dopaminergic neurons in coculture of rat mesencephalon with their target on non-target regions","volume":"23","author":"Akaneya","year":"1995","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.ejphar.2013.04.029_bib2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2013.04.029_bib3","first-page":"3751","article-title":"Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones","volume":"38","author":"Biedler","year":"1978","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2013.04.029_bib4","doi-asserted-by":"crossref","first-page":"12584","DOI":"10.1073\/pnas.91.26.12584","article-title":"Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium","volume":"91","author":"Buck","year":"1994","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.ejphar.2013.04.029_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-079X.2005.00209.x","article-title":"Melatonin protects against MPTP\/MPP+ -induced mitochondrial DNA oxidative damage in vivo and in vitro","volume":"39","author":"Chen","year":"2005","journal-title":"J. Pineal. Res."},{"key":"10.1016\/j.ejphar.2013.04.029_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.mito.2009.06.001","article-title":"Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models","volume":"9","author":"Dagda","year":"2009","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ejphar.2013.04.029_bib7","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/0006-2952(79)90544-6","article-title":"Serotonergic activity of a novel tetrahydro-beta-carboline","volume":"28","author":"Davis","year":"1979","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.04.029_bib8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson's disease","volume":"302","author":"Dawson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2013.04.029_bib9","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/0024-3205(94)00520-6","article-title":"Induction of adenylate cyclase sensitive dopamine D2-receptors in retinoic acid induced differentiated human neuroblastoma SHSY-5Y cells","volume":"55","author":"Farooqui","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2013.04.029_bib10","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1073\/pnas.040556597","article-title":"Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease","volume":"97","author":"Hartmann","year":"2000","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2013.04.029_bib11","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1248\/cpb.22.1600","article-title":"Phlogistic activity of secalonic acid A","volume":"22","author":"Harada","year":"1974","journal-title":"Chem. Pharm. Bull. (Tokyo)."},{"key":"10.1016\/j.ejphar.2013.04.029_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF03159727","article-title":"Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse","volume":"10","author":"Heikkila","year":"1989","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.ejphar.2013.04.029_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0002-9343(00)00291-6","article-title":"Apoptosis and neurologic disease","volume":"108","author":"Honig","year":"2000","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2013.04.029_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2013.04.029_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0306-4522(01)00488-2","article-title":"Stimulation of non-alpha7 nicotinic receptors partially protects dopaminergic neurons from 1-methyl-4-phenylpyridinium-induced toxicity in culture","volume":"109","author":"Jeyarasasingam","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2013.04.029_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejphar.2010.09.063","article-title":"A novel synthetic compound PHID (8-phenyl-6a,7,8,9,9a,10-hexahydro-6H-isoindolo [5,6-g] quinoxaline-7,9-dione) protects SH-SY5Y cells against MPP(+)-induced cytotoxicity through inhibition of reactive oxygen species generation and JNK signaling","volume":"650","author":"Kim","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.04.029_bib17","first-page":"339","article-title":"Cytostatic activity of naturally isolated isomers of secalonic acids and their chemically rearranged dimers","volume":"13","author":"Kurobane","year":"1987","journal-title":"Drugs Exp. Clin. Res."},{"key":"10.1016\/j.ejphar.2013.04.029_bib18","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2013.04.029_bib19","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1126\/science.6332378","article-title":"Pargyline prevents MPTP induced parkinsonism in primates","volume":"225","author":"Langston","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2013.04.029_bib20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1128\/MCB.19.1.751","article-title":"Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death","volume":"19","author":"Le-Niculescu","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2013.04.029_bib21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ejcb.2008.03.003","article-title":"Kynurenic acid attenuates MPP(+)-induced dopaminergic neuronal cell death via a Bax-mediated mitochondrial pathway","volume":"87","author":"Lee","year":"2008","journal-title":"Eur. J. Cell. Biol."},{"key":"10.1016\/j.ejphar.2013.04.029_bib22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neulet.2006.08.053","article-title":"Leptin inhibits 1-methyl-4-phenylpyridinium induced cell death in SH-SY5Y cells","volume":"407","author":"Lu","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2013.04.029_bib23","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1124\/jpet.102.044370","article-title":"5-hydroxytryptamine 1A receptor activation protects against N-methyl-d-aspartate-induced apoptotic cell death in striatal and mesencephalic cultures","volume":"304","author":"Madhavan","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.04.029_bib24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1471-4159.2003.01666.x","article-title":"Tetrahydrobiopterin precursor sepiapterin provides protection against neurotoxicity of 1-methyl-4-phenylpyridinium in nigral slice cultures","volume":"85","author":"Madsen","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2013.04.029_bib25","first-page":"455","article-title":"Neuronal cell death in nervous system development, disease, and injury","volume":"7","author":"Martin","year":"2001","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2013.04.029_bib26","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1471-4159.1990.tb01935.x","article-title":"Toxicity of 1-methyl-4-phenylpyridinium for rat dopaminergic neurons in culture: selectivity and irreversibility","volume":"54","author":"Michel","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2013.04.029_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00702-003-0063-1","article-title":"Ginsenosides Rb1 and Rg1 effects on survival and neurite growth of MPP+-affected mesencephalic dopaminergic cells","volume":"111","author":"Radad","year":"2004","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.ejphar.2013.04.029_bib28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0955-0674(97)80061-0","article-title":"Mitogen-activated protein kinase pathways","volume":"9","author":"Robinson","year":"1997","journal-title":"Curr. Opin. Cell. Biol."},{"key":"10.1016\/j.ejphar.2013.04.029_bib29","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1523\/JNEUROSCI.22-16-07006.2002","article-title":"An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage","volume":"22","author":"Sherer","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2013.04.029_bib30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0168-0102(03)00163-9","article-title":"Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture","volume":"46","author":"Shimizu","year":"2003","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.ejphar.2013.04.029_bib31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neulet.2012.05.063","article-title":"Chrysotoxine, a novel bibenzyl compound selectively antagonizes MPP+, but not rotenone, neurotoxicity in dopaminergic SH-SY5Y cells","volume":"521","author":"Song","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2013.04.029_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0952-7915(96)80131-2","article-title":"Mitogen-activated protein kinase cascades and regulation of gene expression","volume":"8","author":"Su","year":"1996","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ejphar.2013.04.029_bib33","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining","volume":"77","author":"Tatton","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2013.04.029_bib34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.brainresbull.2010.06.014","article-title":"Gypenosides protects dopaminergic neurons in primary culture against MPP (+)-induced oxidative injury","volume":"83","author":"Wang","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2013.04.029_bib35","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.neuropharm.2007.03.017","article-title":"Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity","volume":"52","author":"Wang","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2013.04.029_bib36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1042\/bj3330291","article-title":"The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival","volume":"333","author":"Wang","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2013.04.029_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0166-2236(98)01362-9","article-title":"Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias","volume":"22","author":"West","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2013.04.029_bib38","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.mcn.2003.11.011","article-title":"Suppression of caspase-3-dependent proteolytic activation of protein kinase C delta by small interfering RNA prevents MPP+-induced dopaminergic degeneration","volume":"25","author":"Yang","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2013.04.029_bib39","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/35037739","article-title":"Apoptosis in the nervous system","volume":"407","author":"Yuan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2013.04.029_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuint.2010.10.016","article-title":"Secalonic acid A reduced colchicine cytotoxicity through suppression of JNK, p38 MAPKs and calcium influx","volume":"58","author":"Zhai","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2013.04.029_bib41","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuropharm.2006.08.020","article-title":"The novel squamosamide derivative (compound FLZ) attenuated 1-methyl, 4-phenyl-pyridinium ion (MPP+)-induced apoptosis and alternations of related signal transduction in SH-SY5Y cells","volume":"52","author":"Zhang","year":"2007","journal-title":"Neuropharmacology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913003348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913003348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T11:34:54Z","timestamp":1563017694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299913003348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":41,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0014299913003348"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.04.029","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+)-induced cell death via the mitochondrial apoptotic pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}